Stock listing
IUL Stock Price, News, Filings & Events — Immucell Corporation
Selected listing: IUL · FWB · EUR · DE
This page tracks Immucell Corporation's IUL:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IUL:FWB. IUL:FWB is the stock-level entry point for investors researching Immucell Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- IUL:FWB
- Asset type
- Stock
- Market cap
- $90.4M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- FWB
- Currency
- EUR
Immucell Corporation IUL:FWB stock context
This page tracks Immucell Corporation's IUL:FWB listing on FWB in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following IUL:FWB. IUL:FWB is the stock-level entry point for investors researching Immucell Corporation, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Immucell Corporation
ImmuCell Announces Unaudited Financial Results for the Quarter Ended June 30, 2026
August 13, 2026
ImmuCell Announces a 12% Increase in Product Sales in Q2 of 2026 and a 21% Increase in the First Six Months of 2026, Based on Preliminary, Unaudited Sales Results
July 9, 2026
ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2026
May 14, 2026
ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026
May 7, 2026
ImmuCell Bolsters its Innovation Strategy with Appointments of Dr. Gilles Guillemette and Dr. Anthony DiMarco to the Board, and Moves to a Smaller Board of Independent Directors
April 13, 2026
Immucell Corporation earnings calls
ImmuCell Corporation (ICCC) Q2 2026 Earnings Call
August 14, 2026 · Replay with transcript and chapters
ImmuCell Corporation (ICCC) Q1 2026 Earnings Call
May 15, 2026 · Replay with transcript and chapters
ImmuCell Corporation (ICCC) Q4 2025 Earnings Call
January 9, 2026 · Replay with transcript and chapters
ImmuCell Corporation (ICCC) Q3 2025 Earnings Call
November 14, 2025 · Replay with transcript and chapters
ImmuCell Corporation (ICCC) Q2 2025 Earnings Call
August 15, 2025 · Replay with transcript and chapters
ImmuCell Corporation (ICCC) Q1 2025 Earnings Call
May 15, 2025 · Replay with transcript and chapters
Research Immucell Corporation
Immucell Corporation investor report
Review AI stock analysis and investor report context for IUL:FWB.
Immucell Corporation company profile
View the public company page for Immucell Corporation on 6ix.
Immucell Corporation news
Read company news and market updates connected to Immucell Corporation.
Immucell Corporation investor events
Find investor webinars, events, and replay context for Immucell Corporation.